Silihan lan utang jangka dawa perusahaan Cutera Inc. (CUTR)

Simbol resmi perusahaan Cutera Inc (CUTR)

The implementation of a cost-reduction strategy and the market launch of new AviClear acne treatment systems are creating positive momentum, with the indicator standing at 0.00. Cutera, Inc. is expanding its presence through partnerships with dermatologists by deploying innovative laser technologies. This chart of current share prices complements the picture of a business that generates revenue from services and consumables for aesthetic equipment.

CUTR (Cutera Inc) riwayat Utang jangka dawa perusahaan saka 04.07.2022 nganti 22.03.2025
Produk seri Cutera, Inc

Cutera, Inc. (CUTR) operates a business subject to consumer demand for aesthetic services, which drops sharply when real disposable income declines. Under such conditions, long-term liabilities determine the company's financial resilience to cyclical downturns. This metric captures the volume of borrowed capital with a maturity of over one year, reflecting the debt financing strategy. A decrease in this indicator may signal either a balance sheet recovery or investment stagnation. By analyzing the issuer's long-term liability statistics, an investor can determine the actual pace of the business's deleveraging.

Perusahaan pesaing

dexcom.com - Utang jangka dawa|Utang jangka dawa perusahaan Penumbra (PEN)|NOVT - Silihan lan utang jangka dawa perusahaan|HAE: Utang jangka dawa perusahaan|INSP (Inspire Medical Systems Inc) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan PROCEPT BioRobotics PRCT|Kewajiban jangka dawa conmed.com|Pulse Biosciences - Utang jangka dawa perusahaan|Utang jangka dawa InMode Ltd INMD|Kewajiban jangka dawa perusahaan PMI (Picard Medical Inc.)|SRDX - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan Senseonics Holdings, Inc. SENS|NPCE - Gedhene kewajiban jangka dawa|tactilemedical.com - Utang jangka dawa perusahaan|SANUWAVE Health (SNWV) - Gunggunge utang jangka dawa|Utang jangka dawa perusahaan OM|Kewajiban jangka dawa perusahaan Electromed Inc (ELMD)|LENSAR, Inc. (LNSR) - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan RCEL (avitamedical.com)|Profound Medical - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan Baird Medical Investment Holdings BDMD|EDAP (EDAP Medical) - Utang jangka dawa perusahaan|APYX - Utang jangka dawa|Utang jangka dawa perusahaan icecure-medical.com|Pulmonx (LUNG) - Tanggungan utang jangka dawa perusahaan|TELA: Utang jangka dawa perusahaan|Gunggunge utang jangka dawa CytoSorbents Corp.|Utang jangka dawa perusahaan SRTS (Sensus Healthcare Corp)|Kewajiban jangka dawa perusahaan Zynex Corp (ZYXI)|Utang jangka dawa perusahaan ECOR (electroCore)|Vicarious Surgical Inc - Utang jangka dawa perusahaan|IINN - Utang jangka dawa perusahaan|SeaStar Medical Holding Corporation (ICU) - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan iridex.com IRIX|Intelligent Bio Solutions Inc. (INBS) - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan XAIR (Beyond Air Inc)|Utang jangka dawa PFSA|SSKN: Utang jangka dawa perusahaan|Tanggungan jangka dawa GlucoTrack Inc. GCTK|Kewajiban jangka dawa perusahaan NAOV (NanoVibronix, Inc.)|Utang jangka dawa perusahaan Venus Concept Corporation VERO|Utang jangka dawa perusahaan NUWE (Nuwellis, Inc.)|AEMD: Gunggunge utang jangka dawa|Utang jangka dawa perusahaan asensus.com (ASXC)|AVGR (Avinger Inc.) - Kewajiban jangka dawa|Utang jangka dawa perusahaan BSGM|Kewajiban jangka dawa perusahaan Know Labs Corporation|Inari Medical, Inc. - Utang jangka dawa perusahaan|Utang jangka dawa NVRO (nevro.com)|RSLS - Utang jangka dawa perusahaan|SILK - Tanggungan utang jangka dawa perusahaan